Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT

Rocket Pharmaceuticals (RCKT) Balance Sheet

855 Followers

Rocket Pharmaceuticals Balance Sheet

Rocket Pharmaceuticals's total assets for Q1 2024 were $499.44M, a decrease of -16.59% from the previous quarter. RCKT total liabilities were $57.94M for the fiscal quarter, a 0.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 566.34M$ 551.81M$ 497.02M$ 590.82M$ 372.12M
Total Liabilities
$ 73.77M$ 62.12M$ 42.30M$ 87.31M$ 64.82M
Total Equity Gross Minority
$ 492.57M$ 489.69M$ 454.72M$ 503.52M$ 307.30M
Total Capitalization
$ 514.90M$ 510.04M$ 454.72M$ 538.59M$ 352.35M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 21.76M$ 2.40M
Currency in USD

Rocket Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis